The effects of chlorpropamide and insulin on serum lipids, lipoproteins and fractional triglyceride removal

No abstract is available for this paper.

• Publication year

  1978

• Venue

  Diabetologia

• Publication date

  1978-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/BF00422249PMID 700275
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Serum cholesterol, lipoproteins, and the risk of coronary heart disease. The Framingham study.

  2020cited by this paper
• Effect of chlorpropamide treatment on serum lipid levels in diabetes mellitus.

  2009cited by this paper
• [Atherosclerosis in diabetes mellitus].

  1989cited by this paper
• High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study.

  1977cited by this paper
• Association of serum lipids and obesity with cardiovascular mortality.

  1977cited by this paper
• The Tromsø heart-study. High-density lipoprotein and coronary heart-disease: a prospective case-control study.

  1977cited by this paper
• The influence of a proceeding intravenous glucose load on the intravenous fat tolerance test in man

  1976cited by this paper
• Plasma-high-density-lipoprotein concentration and development of ischaemic heart-disease.

  1975cited by this paper
• Blood lipids in treated diabetics

  1974cited by this paper
• Atherosclerosis in Diabetes Mellitus: Correlations With Serum Lipid Levels, Adiposity, and Serum Insulin Level

  1972cited by this paper
• A photometric modification of the intravenous fat tolerance test.

  1972cited by this paper
• Plasma Triglyceride and Fatty Acid Metabolism in Diabetes mellitus

  1972cited by this paper
• Plasma lipoproteins in adult diabetes.

  1972cited by this paper
• Ischaemic heart-disease in relation to fasting values of plasma triglycerides and cholesterol. Stockholm prospective study.

  1972cited by this paper
• Serum insulin, glucose, and lipid levels among mild diabetics in relation to incidence of vascular complications.

  1971cited by this paper
• Factors associated with long-term survival of diabetics.

  1970cited by this paper
• Rapid method for the isolation of lipoproteins from human serum by precipitation with polyanions.

  1970cited by this paper
• Application of a new intravenous fat tolerance test in the study of hypertriglyceridaemia in man.

  1969cited by this paper
• Practical methods for plasma lipoprotein analysis.

  1968cited by this paper
• Effect of Oral Sulfonylurea on Plasma Triglycerides in Diabetics

  1964cited by this paper
• Immunoassay of Insulin: Two Antibody System: Plasma Insulin Levels of Normal, Subdiabetic and Diabetic Rats

  1963cited by this paper
• Vascular disease and serum lipids in diabetes mellitus. Observations over thirty years (1931-1961).

  1963cited by this paper

• HIGH SENSITIVITY C-REACTIVE PROTEIN AND PLASMA LIPIDS IN TYPE 2DIABETIC PATIENTS IN ENUGU, NIGERIA.

  2017cites this paper
• The Effects of Glibenclamide and Insulin on Plasma High Density Lipoproteins in Diabetics

  2012cites this paper
• Sulphonylurea Antidiabetic Drugs

  2012cites this paper
• Stopping insulin treatment in middle-aged diabetic patients with high postglucagon plasma C-peptide. Effect on glycaemic control, serum lipids and lipoproteins.

  2009cites this paper
• Thematic review series: Patient-Oriented Research. What have we learned about HDL metabolism from kinetics studies in humans? Published, JLR Papers in Press, May 9, 2006.

  2006cites this paper
• Lipoprotein lipase activity and serum lipoproteins in untreated Type 2 (insulin-independent) diabetes associated with obesity

  2004cites this paper
• OSOBITOSTI HIPERLIPOPROTEINEMIJA U INZULIN NEOVISNOM DIJABETESU

  2003cites this paper
• Lipid disorders in type 1 and type 2 diabetes.

  2001cites this paper
• Inefficiency of insulin therapy to correct apolipoprotein A-I metabolic abnormalities in non-insulin-dependent diabetes mellitus.

  2000cites this paper
• Effect of insulin therapy on macrovascular risk factors in type 2 diabetes.

  1999cites this paper
• Lipid and Lipoprotein Responses to Oral Combined Hormone Replacement Therapy in Normolipemic Obese Women with Controlled Type 2 Diabetes Mellitus

  1998cites this paper
• Management of Dyslipidemia in Adults With Diabetes

  1998cites this paper
• CARDIOVASCULAR EFFECTS OF ORAL HYPOGLYCAEMIC DRUGS

  1996cites this paper
• Triglyceride‐rich lipoproteins in non‐insulin‐dependent diabetes mellitus: post‐prandial metabolism and relation to premature atherosclerosis

  1996cites this paper
• Diabetic dyslipidemia: effects of diabetes control, diet and drug therapy.

  1996cites this paper
• Treatment of Dyslipoproteinaemia in Diabetes Mellitus

  1996cites this paper
• Daytime Glibenclamide and Bedtime NPH Insulin Compared to Intensive Insulin Treatment in Secondary Sulphonylurea Failure: a 1‐Year Follow‐up

  1996cites this paper
• One year comparative trial of metformin and glipizide in type 2 diabetes mellitus.

  1994cites this paper
• Lipoprotein compositional abnormalities and insulin resistance in type II diabetic patients with mild hyperlipidemia.

  1993cites this paper
• Understanding and Treating Dyslipidemia Associated With Noninsulin‐Dependent Diabetes Mellitus and Hypertension

  1993cites this paper
• Improvement of lipid profile in Type 2 (non-insulin-dependent) diabetes mellitus by insulin-like growth factor I

  1993cites this paper
• Possible Link Between a Low Prevalence of Cardiovascular Disease and Mild Dyslipidaemia: a Study in Japanese Patients with Type 2 Diabetes

  1993cites this paper
• Does Glycemic Control of Type II Diabetes Suffice to Control Diabetic Dyslipidemia?: A Community Perspective

  1992cites this paper
• Diabetic Macrovascular Disease and Serum Lipids: Is There a Connection?

  1992cites this paper
• Comparison of insulin regimens in patients with non-insulin-dependent diabetes mellitus.

  1992cites this paper
• Effects of combination therapy with glyburide and insulin on serum lipid levels in NIDDM patients with secondary sulfonylurea failure.

  1992cites this paper
• Management of hyperlipidemia in diabetes mellitus.

  1992cites this paper
• Effects of continuous insulin infusion therapy on lipoprotein surface and core lipid composition in insulin-dependent diabetes mellitus.

  1991cites this paper
• The effects of oral hypoglycaemic drugs on serum lipids and lipoproteins in non-insulin-dependent diabetes (NIDDM).

  1991cites this paper
• Management of newly diagnosed non-insulin-dependent (type 2) diabetes mellitus: a retrospective audit.

  1991cites this paper
• Treatment of diabetes: the effect on serum lipids and lipoproteins.

  1991cites this paper
• Relationship of Metabolic Control and Body Weight to Hypercholesterolemia in NIDDM Patients With Apolipoprotein E4

  1991cites this paper
• Hyperlipidemia in diabetes mellitus.

  1990cites this paper
• Effect of Insulin Therapy on Metabolic Fate of Apolipoprotein B–Containing Lipoproteins in NIDDM

  1990cites this paper
• Combination of Insulin with Glipizide Increases Peripheral Glucose Disposal in Secondary Failure Type 2 Diabetic Patients

  1990cites this paper
• Treatment of NIDDM With Insulin Agonists or Substitutes

  1990cites this paper
• Pathophysiology of Hyperlipidemia in Diabetes Mellitus

  1990cites this paper
• Lipoproteins and Apolipoproteins in Young Nonobese Arab Women With NIDDM Treated With Insulin

  1989cites this paper
• The effect of treatment of non-insulin-dependent diabetes mellitus (NIDDM) on serum lipids and lipoproteins.

  1989cites this paper
• Lack of awareness and treatment of hyperlipidemia in type II diabetes in a community survey.

  1989cites this paper
• Sulphonylurea antidiabetic drugs. An update of their clinical pharmacology and rational therapeutic use.

  1989cites this paper
• Lipids, Diabetes, and Vascular Disease: The Time to Act

  1989cites this paper
• Lipoprotein subfraction composition in non-insulin-dependent diabetes treated by diet, sulphonylurea, and insulin.

  1989cites this paper
• Therapeutic aspects of hyperlipidaemia in diabetes.

  1989cites this paper
• Glyburide or insulin for metabolic control in non-insulin-dependent diabetes mellitus. A randomized, double-blind study.

  1988cites this paper
• Insulin Therapy Induces Antiatherogenic Changes of Serum Lipoproteins in Noninsulin‐Dependent Diabetes

  1988cites this paper
• The Effect of Glibenclamide and Metformin on Serum Lipoproteins in Type 2 Diabetes

  1988cites this paper
• Polyunsaturated and Saturated Fat, Cholesterol, and Fatty Add Supplementation

  1988cites this paper
• Effect of insulin therapy on lipoproteins in non-insulin dependent diabetes mellitus (NIDDM).

  1987cites this paper
• Adverse Cardiovascular Effects of Sulphonylurea Drugs

  1987cites this paper
• Lipoprotein metabolism in diabetes mellitus.

  1987cites this paper
• Modification of Therapy From Insulin to Chlorpropamide Decreases HDL Cholesterol in Patients With Non-Insulin-Dependent Diabetes Mellitus

  1987cites this paper
• Abnormal lipoprotein metabolism in non-insulin-dependent diabetes mellitus. Pathogenesis and treatment.

  1987cites this paper
• HDL metabolism in diabetes.

  1987cites this paper
• Abnormal composition of apoproteins C-I, C-II, and C-III in plasma and very-low-density lipoproteins of non-insulin-dependent diabetic Chinese.

  1986cites this paper
• Effects of NIDDM on Very-Low-Density Lipoprotein Triglyceride and Apolipoprotein B Metabolism: Studies Before and After Sulfonylurea Therapy

  1986cites this paper
• High-density lipoprotein subclasses in diabetes.

  1986cites this paper
• Relationship between metabolic control and HDL2-cholesterol in type I diabetic patients

  1986cites this paper
• Serum Lipids and Lipoproteins in Newly Diagnosed Non-insulin-dependent (Type II) Diabetic Patients, with Special Reference to Factors Influencing HDL-Cholesterol and Triglyceride Levels

  1986cites this paper
• Reduced plasma high density lipoprotein-cholesterol concentrations need not increase when hyperglycemia is controlled with insulin in noninsulin-dependent diabetes mellitus.

  1986cites this paper
• Diabetic vascular disease.

  1986cites this paper
• Chlorpropamide Lowers Serum and Lipoprotein Cholesterol in Insulin‐Dependent Diabetes

  1986cites this paper
• Effects of glyburide therapy on lipoproteins in non-insulin-dependent diabetes mellitus.

  1985cites this paper
• Influence of various therapies on hyperlipidemia in diabetes mellitus.

  1985cites this paper
• The 24‐Hour Effects of Glyburide and Chlorpropamide After Chronic Treatment of Type II Diabetic Patients

  1985cites this paper
• Effect of sulfonylurea therapy on plasma lipids and high-density lipoprotein composition in non-insulin-dependent diabetes mellitus.

  1985cites this paper
• Combination insulin/glyburide therapy in type II diabetes mellitus. Effects on lipoprotein metabolism and glucoregulation.

  1985cites this paper
• The role of oral hypoglycemic agents in therapy and prevention of macrovascular complications.

  1985cites this paper
• Lipid and lipoprotein aberrations in Indian patients with non-insulin-dependent diabetes in the young.

  1985cites this paper
• Plasma Lipids and Lipoprotein Cholesterol in Undernourished Diabetic Subjects and Adults with Protein Energy Malnutrition

  1984cites this paper
• Association of Differing Dietary, Metabolic, and Clinical Risk Factors with Microvascular Complications of Diabetes: A Prevalence Study of 503 Mexican Type II Diabetic Subjects. II

  1984cites this paper
• Concomitant insulin and sulfonylurea therapy in patients with type II diabetes. Effects on glucoregulation and lipid metabolism.

  1984cites this paper
• Diabetes as an atherogenic factor.

  1984cites this paper
• CORONARY HEART DISEASE, DIABETES AND CIRCULATING LIPOPROTEIN CHOLESTEROL

  1984cites this paper
• Chromium deficiency and cardiovascular risk.

  1984cites this paper
• Correlation of Serum Lipids with Diabetes Control in Sulfonylurea-treated Diabetic Patients

  1984cites this paper
• Changes in HDL subfractions after a single, extended episode of physical exercise.

  1983cites this paper
• Effects of Hormones on Plasma Lipoprotein Concentrations

  1983cites this paper
• The Response of Plasma Triglyceride, Cholesterol, and Lipoprotein Lipase to Treatment in Non-insulin-dependent Diabetic Subjects Without Familial Hypertriglyceridemia

  1983cites this paper
• Plasma HDL in non-insulin-dependent diabetes and the effect of various types of treatment.

  1983cites this paper
• Apolipoproteins (A-I, A-II, B), Lp(a) lipoprotein and lecithin: cholesterol acyltransferase activity in diabetes mellitus.

  1983cites this paper
• DISTRIBUTION OF CHOLESTEROL AMONG LIPOPROTEIN FRACTIONS IN DIABETES MELLITUS

  1983cites this paper
• The effect of oral hypoglycemic agents on the lipid levels in non-insulin-dependent diabetes in the young.

  1982cites this paper
• Effect of bezafibrate on plasma lipids, lipoproteins, apolipoproteins AI, AII and B and LCAT activity in hyperlipidemic, non-insulin-dependent diabetics.

  1982cites this paper
• Abnormal Composition of High Density Lipoproteins in Non-insulin-dependent Diabetics

  1982cites this paper
• Hemoglobin A1 correlates with the ratio of low-to high-density-lipoprotein cholesterol in normal weight type II diabetics.

  1982cites this paper
• Hyperglycemia, including oral hypoglycemic agents.

  1982cites this paper
• Chronic chlorpropamide therapy of noninsulin-dependent diabetes augments basal and stimulated insulin secretion by increasing islet sensitivity to glucose.

  1982cites this paper
• Significance of linoleic acid in the metabolism and therapy of diabetes mellitus.

  1982cites this paper
• High-density lipoprotein cholesterol: methods and clinical significance.

  1982cites this paper
• High density lipoprotein cholesterol and apolipoprotein a-1 concentrations in non-insulin dependent diabetics treated by diet and chlorpropamide.

  1982cites this paper
• Hyperlipidemia and diabetes.

  1982cites this paper
• 血清HDL-cholesterol に及ぼす糖尿病治療および Pantethine の影響

  1981cites this paper
• An expanded concept of "insurance" supplementation--broad-spectrum protection from cardiovascular disease.

  1981cites this paper
• Plasma high density lipoprotein cholesterol in streptozotocin diabetic and non-diabetic mice after prolonged administration of glibenclamide, chlorpropamide and metformin.

  1981cites this paper
• Comparison on sulphonylurea and insulin treatment on lipid levels in maturity-onset diabetic men and women.

  1981cites this paper
• Lipoprotein patterns in diet, sulphonylurea, and insulin treated diabetics

  1981cites this paper
• Hypoglycaemic drugs.

  1981cites this paper
• Acceleration of Low-Density Lipoprotein Catabolism in Man by Total Parenteral Nutrition

  1981cites this paper
• High Density Lipoproteins in Diabetes

  1981cites this paper